Comment from Generic Animal Drug Alliance (GADA)
AnonymousSupportAdvocacy
Summary: The Generic Animal Drug Alliance (GADA) supports the existing SUPAC guidances as helpful and meaningful tools for planning regulatory strategies and managing post-approval changes. However, they request specific improvements, including more examples, clearer definitions, better alignment with other FDA guidances, and the incorporation of Q&A content into the primary guidance documents.
The Generic Animal Drug Alliance (GADA) appreciates the opportunity to provide comments on the FDA request for information regarding the SUPAC guidances.